SFTPA1 | Surfactant protein A1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SFTPB | Surfactant protein B | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SFTA3 | Surfactant associated 3 | | | | | | Group enriched |
SFTPA2 | Surfactant protein A2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SFTPC | Surfactant protein C | Disease related genes
| | | | | Tissue enriched |
SCGB3A2 | Secretoglobin, family 3A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
NKX2-1 | NK2 homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
ROS1 | C-ros oncogene 1 , receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SFTPD | Surfactant protein D | Predicted secreted proteins
| | | | | Tissue enriched |
SCN1A | Sodium channel, voltage-gated, type I, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
CCDC37 | Coiled-coil domain containing 37 | | | | | | Group enriched |
MS4A15 | Membrane-spanning 4-domains, subfamily A, member 15 | Predicted membrane proteins
| | | | | Tissue enriched |
DNAH12 | Dynein, axonemal, heavy chain 12 | Cancer-related genes
| | | | | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RTKN2 | Rhotekin 2 | | | | | | Tissue enriched |
CHIA | Chitinase, acidic | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DLEC1 | Deleted in lung and esophageal cancer 1 | Disease related genes Plasma proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
WDR96 | WD repeat domain 96 | | | | | | Group enriched |
FCN3 | Ficolin (collagen/fibrinogen domain containing) 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GGTLC1 | Gamma-glutamyltransferase light chain 1 | | | | | | Group enriched |
NAPSA | Napsin A aspartic peptidase | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
DNAAF1 | Dynein, axonemal, assembly factor 1 | Disease related genes
| | | | | Group enriched |
RP11-664D7.4 | HCG1787533; Uncharacterized protein | | | | | | Group enriched |
LRRN4 | Leucine rich repeat neuronal 4 | Predicted membrane proteins
| | | | | Tissue enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC46A2 | Solute carrier family 46, member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
UPK3B | Uroplakin 3B | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
C19orf59 | Chromosome 19 open reading frame 59 | Predicted membrane proteins
| | | | | Group enriched |
ICAM5 | Intercellular adhesion molecule 5, telencephalin | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
KHDC3L | KH domain containing 3-like, subcortical maternal complex member | Disease related genes
| | | | | Group enriched |
PLA2G4F | Phospholipase A2, group IVF | Enzymes RAS pathway related proteins
| | | | | Group enriched |
SCGB1A1 | Secretoglobin, family 1A, member 1 (uteroglobin) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SFTA2 | Surfactant associated 2 | Predicted secreted proteins
| | | | | Tissue enriched |
SLC22A31 | Solute carrier family 22, member 31 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C10orf67 | Chromosome 10 open reading frame 67 | | | | | | Group enriched |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Transporters
| | | | | Tissue enriched |
FRMPD2 | FERM and PDZ domain containing 2 | Cytoskeleton related proteins Predicted secreted proteins
| | | | | Group enriched |
LAMP3 | Lysosomal-associated membrane protein 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |